DendroPharm GmbH develops cutting-edge nanotechnology drug delivery systems designed to bring APIs precisely to their target. Our dendritic core-multishell nanocarriers enhance bioavailability, increase skin penetration, and reduce side effects. As a strategic partner for pharmaceutical companies, startups, we offer tailored CDMO services, including custom synthesis, GMP analytics, and small-batch GMP manufacturing — from early development to clinical sample production.